SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: franco who wrote ()2/27/1998 4:49:00 PM
From: Phil Cressman  Read Replies (2) of 4650
 
I checked out the web site for Biomoda and did a full review of the data presented there. I have more than a few questions about information which was not posted here! What are the financials of Biomoda the chemical marker looks interesting but who else out there has competing processes and at what clinical trials stage are they! Fda approval for the use of this marker for detection alone will take a few years and likely several million dollars. If Biomoda has good preliminary data why would they not partner with a more senior biopharmaceutical company? I hate to sound like I am trashing this company as I would really like to take an investment position IF there is a good chance of an improvement in the detection/treatment of lung cancer. Financials are important but so are valid clinical evaluations of technology that are completed by unbiased outside agencies. I note that Biomoda's initial IPO was for 600,000 shares at $5.00 each. What did ADOT pay for their share in this company?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News